Neuronal tauopathy in progressive supranuclear palsy (PSP) represents the core neuropathological feature characterizing this 4R-tauopathy. Unlike Alzheimer's disease, where neurons bear the primary burden of tau pathology, PSP exhibits a distinctive pattern of neuronal involvement alongside significant glial pathology. The affected neuronal populations determine the characteristic clinical phenotype of PSP, including vertical gaze palsy, postural instability, and akinesia.
The brainstem is severely affected in PSP, with specific neuronal populations showing pronounced vulnerability:
- Dopaminergic neurons in the substantia nigra show early and severe tau pathology
- Neurofibrillary tangles (NFTs) replace neuromelanin granules
- Neuronal loss correlates with disease duration
- Clinical correlation: Parkinsonian rigidity and bradykinesia
- Pontine reticular formation neurons degenerate
- Contributing to vertical gaze palsy
- Involvement of the paramedian pontine reticular formation (PPRF)
- Third nerve nuclei (CN III): Superior rectus, inferior rectus, inferior oblique, medial rectus
- Fourth nerve nuclei (CN IV): Trochlear nucleus
- Sixth nerve nuclei (CN VI): Abducens nucleus
- Clinical correlation: Vertical supranuclear gaze palsy, slowing of saccades
- Large neurons in the red nucleus show tau pathology
- Interconnected with the basal ganglia and cerebellum
- May contribute to movement coordination deficits
- Internal segment (GPi): Severely affected, massive neuronal loss
- External segment (GPe): Moderately involved
- Clinical correlation: Axial rigidity, postural instability
- Small neurons show early tau pathology
- Highly vulnerable to tau accumulation
- Clinical correlation: Falls, gait dysfunction
- Medium spiny neurons show some involvement
- Less affected than in Huntington's disease
- GABAergic output remains relatively preserved early
- Dentate nucleus: Globular tau inclusions
- Fastigial nucleus: Involvement correlates with ataxia
- Interposed nuclei: Moderate pathology
- Clinical correlation: Gait ataxia, dysarthria
- Layer III pyramidal neurons: Most affected in cortex
- Layer V pyramidal neurons: Moderate involvement
- Layer VI neurons: Relatively spared
- Clinical correlation: Cognitive impairment, executive dysfunction
- Prefrontal cortex: Severe involvement
- Motor cortex: Moderate involvement
- Occipital cortex: Relatively spared (explains preserved visual perception)
- Temporal cortex: Variable involvement
- Classic NFTs: Flame-shaped, basophilic inclusions
- Pretangles: Early phosphorylated tau accumulation
- Ghost tangles: Remnants of dead neurons
- Distribution: Perikaryal, not nuclear
- Dendritic tau: Accumulations in neuronal processes
- Axonal threads: Small-caliber axons
- Neuropil threads: Dendritic processes
- Granular hazy inclusions: Early tau pathology
- Focal cytoplasmic tau: Focal accumulation patterns
- Perinuclear tau: Ring-like distribution
- Kinase hyperactivity: GSK-3β, CDK5, MAPK activation
- Phosphatase insufficiency: PP1, PP2A dephosphorylation defects
- Hyperphosphorylated tau: AT8, AT100, AT180 epitopes
- Kinesin/dynein dysfunction: Transport disruption
- Synaptic vesicle depletion: Early synaptic pathology
- Soma-to-axon distribution loss: Misrouting
- Complex I deficiency: Energy crisis
- Calcium dysregulation: Excitotoxicity
- Apoptotic pathway activation: Caspase cascades
- Network propagation: Tau spreads along neuronal circuits
- Synaptic connectivity: Pre-synaptic tau entry
- Transsynaptic spread: Oligodendrocyte involvement
- Neuronal subtype markers: Specific vulnerability markers
- Metabolic demands: High-energy neurons affected first
- Calcium handling: Excitotoxicity susceptibility
- Myelination patterns: White matter involvement
- Vasculature: Perfusion differences
- Glial support: Astrocyte and oligodendrocyte interactions
| Feature |
PSP |
CBD |
AD |
| Primary neuronal loss |
Brainstem > Basal Ganglia |
Cortex > Basal Ganglia |
Cortex > Limbic |
| NFT morphology |
Straight filaments |
Twisted filaments |
Paired helical |
| Glial involvement |
Tufted astrocytes |
Astrocytic plaques |
NFT-dominant |
| 4R/3R tau |
4R only |
4R only |
3R+4R |
- Brainstem signs: Vertical gaze palsy → oculomotor nucleus involvement
- Axial rigidity: GPi and STN involvement
- Falls: Basal ganglia and brainstem integration
- Nigrostriatal involvement: Substantia nigra pathology
- Bradykinesia: Dopaminergic loss
- Striatal involvement: Caudate and putamen
- Freezing of gait: Frontal-striatal circuits
- Cortical involvement: Asymmetric apraxia
- Basal ganglia: Contralateral symptoms
- Total tau: Elevated in PSP vs. controls
- Phosphorylated tau: Moderate elevation
- Neurofilament light chain (NfL): Correlates with neuronal loss
- MRI: Midbrain atrophy (Hummingbird sign)
- PET: Tau ligand retention in affected regions
- DTI: White matter tract involvement
- Tau aggregation inhibitors: Small molecule approaches
- Kinase inhibitors: GSK-3β, CDK5 modulators
- Antisense oligonucleotides: MAPT-targeted approaches
- Neurotrophic factors: BDNF, GDNF delivery
- Calcium channel blockers: Excitotoxicity prevention
- Mitochondrial protectants: CoQ10,idebenone